Cargando…
HNRNPK inhibits gastric cancer cell proliferation through p53/p21/CCND1 pathway
Gastric cancer (GC) is one of the most common human cancers. The molecular mechanisms underlying GC carcinogenesis and progression are still not well understood. In this study, we showed that heterogeneous nuclear ribonucleoprotein K (HNRNPK) was an effective prognostic marker for GC patients especi...
Autores principales: | Huang, Hao, Han, Yong, Yang, Xingjiu, Li, Mengyuan, Zhu, Ruimin, Hu, Juanjuan, Zhang, Xiaowei, Wei, Rongfei, Li, Kejuan, Gao, Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732733/ https://www.ncbi.nlm.nih.gov/pubmed/29262567 http://dx.doi.org/10.18632/oncotarget.21873 |
Ejemplares similares
-
Downregulation of HNRNPK in human cancer cells inhibits lung metastasis
por: Li, Mengyuan, et al.
Publicado: (2019) -
ATM targets hnRNPK to control p53
por: Blasius, Melanie, et al.
Publicado: (2013) -
Heterogeneous nuclear ribonucleoprotein K promotes the progression of lung cancer by inhibiting the p53‐dependent signaling pathway
por: Li, Mengyuan, et al.
Publicado: (2022) -
Expressions of p53 and p21 in primary gastric lymphomas.
por: Go, J. H., et al.
Publicado: (2001) -
MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2
por: Li, Yan-Li, et al.
Publicado: (2016)